Suite 2, Level 11, 385 Bourke Street, Melbourne VIC 300 Australia Prescient Therapeutics Limited T - +61 3 9692 7222 | F - +613 9077 9233 | W - ptxtherapeutics.com ABN 56 006 569 106 SPP Presentation Join the CEO of PTX James McDonnell for a live and interactive shareholder...
Prescient Share Purchase Plan Investor Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
Prescient Therapeutics Limited on 6ix
In the deck
Earlier from Prescient Therapeutics
- Prescient Therapeutics Opens SPP to Raise $7m Today
- Share Purchase Plan Cleansing Notice
- Proposed issue of securities - PTX
- Prescient Therapeutics Launches Share Purchase Plan for $7m
- Appendix 4E and 2026 Annual Report
Later from Prescient Therapeutics
- PTX-100 CTCL Phase 2a study reaches review milestone
- Prescient Therapeutics - Extension of Share Purchase Plan
- Update - Proposed issue of securities - PTX
- Notice of Annual General Meeting/Proxy Form
- Trading Halt
Follow Prescient Therapeutics into a list and get an email when it puts out news.
Follow Prescient Therapeutics